-
The Joint Commission takes on the controversial issue of decolonization of patients carrying multidrug-resistant organisms (MDROs) in a new report aimed at health care CEOs.
-
National health care reform must include a quality component including preventing health care-associated infections if it is to become an effective and affordable reality, Mark R. Chassin, MD, president of The Joint Commission, notes in a commentary posted on the Joint Commission web site (http://www.jointcommission.org).
-
-
A randomized controlled trial demonstrated that "perfect" empathy with patients results in a better immune response, reduction of symptoms, and faster recovery from a common cold.
-
Red yeast rice and therapeutic lifestyle changes decrease LDL-cholesterol levels without increasing CPK or pain levels and may be a treatment option for dyslipidemic patients who cannot tolerate statin therapy.
-
A study group in Greece used 3 consecutive different regimens to achieve a 98% eradication rate among 540 patients not lost to follow-up. The success of each individual regimen was about 70%.
-
A new antiplatelet drug has been approved by the FDA for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.
-
Hidradenitis suppurativa (HSP) is regarded both in the dermatology and primary care communities as a "heart sink" diagnosis: Patients are generally chronically burdened, we have little successful treatment, the pathophysiology is poorly understood, and the consequences often have an important negative impact on quality of life.
-
-
